Background-Clinical observations suggest that transplant coronary arte
ry disease (TxCAD) is immunologically mediated but may be accelerated
by metabolic derangements. We developed a rat model of heterotopic hea
rt transplantation in the presence of diabetes and dyslipidemia to fur
ther study their role in TxCAD development. Methods and Results-Major
histocompatibility complex-mismatched strains of inbred rats underwent
heterotopic heart transplantation (ACI-to-Lewis allografts), Diabetes
(DM) was induced by streptozotocin injection (80 mg/kg) after transpl
antation; dyslipidemia was worsened by feeding of a 60% high-fructose
diet (SF), Allograft transplants were divided into four groups: (1) +D
M/+F; (2) +DM/-F; (3) -DM/+F; and (4) -DM/-F, Isograft transplants (Le
wis to Lewis, + DM/+/-F) were controls. All animals received daily cyc
losporine (5 mg/kg). Grafts surviving >30 days were evaluated for TxCA
D on histological sections and graded 0 to 5 for intimal thickness. Al
l streptozotocin-treated animals were diabetic within 2 weeks, with fo
urfold increases in plasma glucose concentrations versus nondiabetics.
Severe TxCAD was observed in diabetic allografts only. The mean grade
of TxCAD in diabetic allografts was 3.2+/-0.5 versus 1.1+/-0.4 in dia
betic isografts (P<0.03) and zero TxCAD in nondiabetic allografts (P l
ess than or equal to 0.0001). Fructose feeding resulted in a 1.5-fold
higher triglyceride and a 1.3-fold higher cholesterol level versus the
regular diet (-F) but showed no independent contribution to the devel
opment of TxCAD. Conclusions These findings suggest that metabolic der
angements associated with diabetes play an important role in TxCAD dev
elopment in heterotopic ACI-to-Lewis rat heart transplantation. In thi
s model of TxCAD in major histocompatibility complex-mismatched, diabe
tic, and dyslipidemic rats, immunologic and metabolic mechanisms that
contribute to TxCAD can be further delineated and approaches to its pr
evention assessed.